Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$351.84M
Total Bought
$23.74M
Total Sold
$41.25M
Net Transaction
-$17.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG ONCOLOGY INC(CGON)1,131,5011,130,501-1,00046,98076,58021.77%+29,600
TERNS PHARMACEUTICALS INC1,746,2641,746,264070,54992,06326.17%+21,514
JADE BIOSCEINCES INC0786,760+786,760011,0543.14%+11,054
ONKURE THERAPEUTICS INC(OKUR)2,839,6742,839,67408,23511,7563.34%+3,521
LEONABIO, INC.(LONA)501,739634,539+132,8003,7986,5231.85%+2,725
CANDEL THERAPEUTICS INC(CADL)2,580,5173,497,948+917,43114,58017,2104.89%+2,630
BICARA THERAPEUTICS643,382643,382010,82812,7973.64%+1,969
PUMA BIOTECHNOLOGY INC(PBYI)4,131,2994,131,299024,58126,3997.50%+1,818
KARYOPHARM THERAPEUTICS INC(KPTI)0287,826+287,82601,6030.46%+1,603
WHITEHAWK THERAPEUTICS INC(WHWK)1,139,3631,139,36302,7573,9311.12%+1,174
AURA BIOSCIENCES INC(AURA)595,744595,74403,2473,9861.13%+739
Q32 BIO INC.(FIXX)493,425315,052-178,3731,6382,0230.57%+384
VYNE THERAPEUTICS INC(YARW)1,4251,4250110.00%0
X4 PHARMACEUTICALS INC(XFOR)273,349234,039-39,3101,0939670.27%-127
PROTARA THERAPEUTICS INC(TARA)1,752,1151,752,11509,3399,1292.59%-210
ACRIVON THERAPEUTICS INC405,2370-405,2379770—-977
TREVI THERAPEUTICS INC(TRVI)2,144,8442,144,844026,85325,5887.27%-1,265
BIOATLA INC(BCAB)4,835,1115,406,345+571,2342,7568650.25%-1,891
JASPER THERAPEUTICS(JSPR)1,786,4921,411,492-375,0003,2691,2420.35%-2,027
CARDIF ONCOLOGY INC(CRDF)1,962,0841,762,084-200,0005,5132,8550.81%-2,659
VERASTEM INC(VSTM)1,469,1531,469,153011,3427,7872.21%-3,555
UROGEN PHARMA LTD(URGN)1,448,4201,673,420+225,00033,92230,0888.55%-3,834
HELUS PHARMA INC.(HELP)1,573,0231,540,266-32,75712,8747,3932.10%-5,481
Page 1 of 1
ACORN CAPITAL ADVISORS, LLC — 13F Holdings — Q1 2026 | TickerTrail